tiprankstipranks
Advertisement
Advertisement

ACXP Stock Latest News

Acurx’s ibezapolstat shows microbe preservation efficacy
The FlyAcurx’s ibezapolstat shows microbe preservation efficacy
7d ago
ACXP
Acurx Pharmaceuticals Charts Risky but Promising CDI Path
PremiumCompany Announcements
Acurx Pharmaceuticals Charts Risky but Promising CDI Path
2M ago
ACXP
Acurx reports Q1 EPS (62c) vs. ($2.15) last year
PremiumThe Fly
Acurx reports Q1 EPS (62c) vs. ($2.15) last year
2M ago
ACXP
Acurx files to sell 1.65M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 1.65M shares of common stock for holders
3M ago
ACXP
Acurx files to sell 1.3M shares of common stock for holders
PremiumThe Fly
Acurx files to sell 1.3M shares of common stock for holders
3M ago
ACXP
Acurx announces $7.1M registered direct offering priced at-the-market
PremiumThe FlyAcurx announces $7.1M registered direct offering priced at-the-market
3M ago
ACXP
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline
Premium
Company Announcements
Acurx Pharmaceuticals Secures New Financing to Advance Pipeline
3M ago
8K
ACXP
New to The Street announce re-signing of Acurx Pharmaceuticals
Premium
The Fly
New to The Street announce re-signing of Acurx Pharmaceuticals
4M ago
ACXP
Acurx: KIPO grantes new patent covering DNA Polymerase IIIC inhibitors
PremiumThe Fly
Acurx: KIPO grantes new patent covering DNA Polymerase IIIC inhibitors
4M ago
ACXP
Acurx price target lowered to $10 from $20 at Alliance Global
PremiumThe Fly
Acurx price target lowered to $10 from $20 at Alliance Global
4M ago
ACXP
Acurx reports Q4 EPS (73c) vs. ($3.29) last year
PremiumThe Fly
Acurx reports Q4 EPS (73c) vs. ($3.29) last year
4M ago
ACXP
Acurx Pharmaceuticals Stock (ACXP) Explodes 218% as New Trial Moves Forward on 96% Cure Rate
PremiumMarket News
Acurx Pharmaceuticals Stock (ACXP) Explodes 218% as New Trial Moves Forward on 96% Cure Rate
4M ago
ACXP
ACXP Earnings this Week: How Will it Perform?
PremiumPre-EarningsACXP Earnings this Week: How Will it Perform?
4M ago
ACXP
Acurx Advances Ibezapolstat Program for Recurrent C. difficile
Premium
Company Announcements
Acurx Advances Ibezapolstat Program for Recurrent C. difficile
4M ago
8K
ACXP
Acurx announces new ibezapolstat clinical trial program
Premium
The Fly
Acurx announces new ibezapolstat clinical trial program
4M ago
ACXP
Acurx files to sell 750,000 shares of common stock for holders
PremiumThe Fly
Acurx files to sell 750,000 shares of common stock for holders
6M ago
ACXP
Acurx awarded patent covering DNA Polymerase IIIC inhibitors by USPTO
PremiumThe Fly
Acurx awarded patent covering DNA Polymerase IIIC inhibitors by USPTO
6M ago
ACXP
One new option listing and option delistings on January 20th
PremiumThe Fly
One new option listing and option delistings on January 20th
6M ago
CVM
TEF
Acurx Pharmaceuticals: Promising Developments and Strategic Advances in Antibiotic Innovation
PremiumRatings
Acurx Pharmaceuticals: Promising Developments and Strategic Advances in Antibiotic Innovation
8M ago
ACXP
Acurx Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsAcurx Pharmaceuticals Reports Q3 2025 Financial Results
8M ago
ACXP
Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges
Premium
Company Announcements
Acurx Pharmaceuticals’ Earnings Call: Achievements Amid Challenges
8M ago
ACXP
Optimistic Buy Rating for Acurx Pharmaceuticals Driven by Promising Developments and Financial Strength
Premium
Ratings
Optimistic Buy Rating for Acurx Pharmaceuticals Driven by Promising Developments and Financial Strength
8M ago
ACXP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >